Transaction raised $2.2 billion, enhancing strategic flexibility to invest for future growth Approximately $290 million of proceeds used to repurchase outstanding Class A common stock $123.2 million of proceeds used to acquire capped calls intended to offset any share dilution elevating conversion price to $174.42 per share With the capped calls, Robinhood anticipates no net dilution from the transaction until its share price exceeds approximately $237.85 or an approximately 154% increase from today’s closing price. Factoring in the share repurchase, Robinhood anticipates no net dilution from the transaction until its share price exceeds $303.95 MENLO PARK, Calif., June 25, 2026 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced the closing of its previously announced private offering of $2.2...

Pricing of CNH Industrial Capital Canada Ltd. Cdn$450 million notes Basildon, June 25, 2026 CNH Industrial N.V. (NYSE: CNH) today announced that its indirect wholly owned subsidiary, CNH Industrial Capital Canada Ltd., has priced Cdn$450 million in aggregate principal amount of 3.80% notes due January 22, 2030, with an issue price of 99.872%. The notes are being offered on a private placement basis to certain accredited investors in each of the provinces of Canada, which offering is expected to close on June 29, 2026, subject to the satisfaction of customary closing conditions. CNH Industrial Capital Canada Ltd. intends to add the net proceeds from the offering to its general funds and use them for working capital and other general corporate purposes, including, among other things, the purchase of receivables or other assets in the ordinary...

Orrön Energy AB (“Orrön Energy” or “the Company”) is pleased to announce that it has entered into an agreement with Cloudberry Clean Energy ASA (“Cloudberry”) to combine the Company’s Nordic renewable energy platform and organisation, excluding the Karskruv windfarm, with Cloudberry (the “Transaction”), creating a leading Nordic independent power producer (“IPP”). As consideration for the Transaction, Orrön Energy will receive 27.01 percent of the shares in the enlarged Cloudberry, becoming its largest shareholder. In addition, loan balances and accrued interest of approximately MEUR 93 as of year-end 2025 will be settled or assumed by Cloudberry, and Orrön Energy will receive MEUR 4.2 in cash. Orrön Energy will take an active role in Cloudberry’s future growth through Board representation, bringing Orrön Energy’s and the Lundin Group’s...

Press release25 June 2026 – N° 14 SCOR acknowledges the arbitration award confirming the validity of the retrocession treaties entered into with Covéa in June 2021 SCOR acknowledges the award issued on June 25, 2026 by the arbitration tribunal in the proceedings initiated in 2022 seeking the enforcement of the retrocession treaties entered into with Covéa in June 2021. These treaties provide for the transfer to Covéa of 30% of the Life & Health portfolio held by SCOR’s Irish entities as at December 31, 2020. The arbitration tribunal confirmed the validity of the treaties, which will continue to be performed in accordance with their terms. The tribunal further found it equitable to award compensation to Covéa in an amount of USD 488.3 million. After taking into account provisions, the impact on SCOR’s net results at Q2 2026 will...

Dubai, June 26, 2026 (GLOBE NEWSWIRE) — Reference is made to the announcement by Vantage Drilling International Ltd. (the “Company”) on 29 May 2026 regarding the proposed merger pursuant to which a wholly owned subsidiary of Eldorado Drilling AS is to merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Eldorado Drilling AS (the “Merger”). The Company is pleased to announce that all conditions to completion of the Merger are expected to be satisfied as of 1:00 PM ET on 26 June 2026, subject to continued satisfaction of customary closing conditions through to that time. Upon completion, shareholders of the Company will receive cash consideration amounting to USD 19.00 per Company share. In order to facilitate an orderly settlement of payment of the consideration, the Company will...

JACKSONVILLE, Fla., June 25, 2026 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its second quarter 2026 earnings results on Wednesday, July 29, 2026, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Thursday, July 30, 2026, at 11:00 a.m. ET.Second Quarter 2026 Earnings Conference CallDate: Thursday, July 30, 2026Time: 11:00 a.m. ETDial#: 877-407-0789 or 201-689-8562Webcast: 2nd Quarter 2026 Webcast LinkReplay Webcast Archive: Investor Relations page under Webcasts & Presentations About Regency Centers Corporation (NASDAQ: REG) Regency Centers...

Addition reflects Eikon’s progress as a publicly traded company and increasing visibility within the investment community MILLBRAE, Calif., June 25, 2026 (GLOBE NEWSWIRE) — Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced that it will be added to the broad-market Russell 3000® Index following the annual reconstitution, effective after the US market closes on June 26, 2026. The Russell US Indexes, from mega cap to microcap, serve as leading benchmarks for institutional investors. The modular index construction allows investors to track current and historical market performance by specific market segment or investment style (growth/value/defensive/dynamic). The Russell 3000 Index...

LITTLE ROCK, Ark., June 25, 2026 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that it will report its second quarter 2026 financial results prior to the opening of trading on the Nasdaq Stock Exchange on July 30, 2026. A conference call to discuss those earnings will be held the same day at 8:30 AM Eastern Time. The conference call will be webcast live on Uniti’s Investor Relations website at investor.uniti.com. Those parties interested in participating via telephone may register on the Investor Relations website or by clicking here. A replay of the call will also be made available on the Investor Relations website. ABOUT UNITI Uniti (NASDAQ: UNIT) is a premier insurgent fiber provider dedicated to enabling mission-critical connectivity across the United States. We build, operate, and deliver fast...

ST. LOUIS, June 25, 2026 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported selected operating results for May 31, 2026, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said, “Total and fee-based client assets increased 18% and 23%, respectively, year-over-year, excluding the sale of Stifel Independent Advisors, LLC. Growth was driven by market appreciation and solid advisor recruiting. Loan balances rose more than 2% from the prior month as demand in fund banking remained robust. Treasury deposits declined 3% in May, which was primarily a function of the timing of inflows and outflows by our corporate clients, but we continue...

Building on Its Recent Acquisition of the CCX0722 Intellectual Property, Cosmos Health Owns the Technology Outright and Is Now Pursuing Patent Protection Across Four Major Healthcare Markets Within the $190+ Billion Global Weight Management CategoryAdvances international patent application WO2025108566A1, titled “Hydrogel for Body Weight Management,” into the U.S., Europe, Australia, and Canada — four of the world’s largest healthcare markets Builds on Cana Laboratories’ acquisition of the patent application from Cloudpharm, bringing full ownership of the underlying intellectual property into the Cosmos Health portfolio, with no licensing fees, royalty-sharing, or third-party IP dependency Three-plus years of disciplined R&D execution — from concept in 2022 through pilot production, scale-up, and final-stage...